Insights Into Management of AEs in CLL 2021

Perspectives of community physicians from Puerto Rico on optimal integration and side effect management of novel therapies

Puerto Rico – August 14, 2021
Purchase Report

Faculty Chair

Javier Pinilla, MD, PhD

Moffitt Cancer Center, Tampa, FL

More Information

  • Virtual series

Example Agenda

Download the meeting agenda

View Agenda

Example Report

Start discovering the insights

View Report

REPORT SNAPSHOT

  • A virtual, moderated roundtable discussion focusing on the treatment of chronic lymphocytic leukemia
  • Disease state and data presentations were developed in conjunction with a national or regional oncology expert
  • Insights on the following therapies were obtained: acalabrutinib, ibrutinib, zanubrutinib, obinutuzumab, rituximab, venetoclax

GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT

  • Data collection was accomplished through use of audience response system questioning and moderated discussion
  • The group of advisors comprised 10–15 medical oncologists representing Puerto Rico

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.